Literature DB >> 28356016

Tetrazole Derivatives as Promising Anticancer Agents.

Elena A Popova1, Aleksandra V Protas1, Rostislav E Trifonov1.   

Abstract

Tetrazole cycle is a promising pharmacophore fragment frequently used in the development of novel drugs. This moiety is a stable, practically non-metabolized bioisosteric analog of carboxylic, cis-amide, and other functional groups. Over recent 10-15 years, various isomeric forms of tetrazole (NH-unsubstituted, 1H-1- substituted, and 2H-2-substituted tetrazoles) have been successfully used in the design of promising anticancer drugs. Coordination compounds of transition metals containing tetrazoles as ligands, semisynthetic tetrazolyl derivatives of natural compounds (biogenic acids, peptides, steroids, combretastatin, etc.), 5-oxo and 5- thiotetrazoles, and some other related compounds have been recognized as promising antineoplastic agents. This review presents a comprehensive analysis of modern approaches to synthesis of these tetrazole derivatives as well as their biological (anticancer) properties. The most promising structure types of tetrazoles to be used as anticancer agents have been picked out. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Tetrazoles; anticancer agents; antitumor agents; cancer; coordination compounds; natural compounds.

Mesh:

Substances:

Year:  2018        PMID: 28356016     DOI: 10.2174/1871520617666170327143148

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  4 in total

1.  Structure-Based Screening of Tetrazolylhydrazide Inhibitors versus KDM4 Histone Demethylases.

Authors:  Piotr H Małecki; Nicole Rüger; Martin Roatsch; Oxana Krylova; Andreas Link; Manfred Jung; Udo Heinemann; Manfred S Weiss
Journal:  ChemMedChem       Date:  2019-10-10       Impact factor: 3.466

2.  Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight.

Authors:  Mohammad G Al-Thiabat; Fadi G Saqallah; Amirah Mohd Gazzali; Noratiqah Mohtar; Beow Keat Yap; Yee Siew Choong; Habibah A Wahab
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

3.  Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2.

Authors:  Wael A El-Sayed; Fahad M Alminderej; Marwa M Mounier; Eman S Nossier; Sayed M Saleh; Asmaa F Kassem
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

4.  New ecofriendly heterogeneous nano-catalyst for the synthesis of 1-substituted and 5-substituted 1H-tetrazole derivatives.

Authors:  Mahboobeh-Sadat Mashhoori; Reza Sandaroos
Journal:  Sci Rep       Date:  2022-09-13       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.